In this study, we demonstrate that the second generation Hsp90 inhibitor AUY922 induces potent inhibition of AR transcription associated with antitumor activity, and increases cell death in combination with docetaxel in castrate resistant prostate cancer cell lines. Here, AR is linked to prostate cancer.